The target for acquisition is Riken Vitamin ordinary shares, totaling 164,300 shares and 536,497,492 yen, acquired through market purchases from August 1 to August 31, 2026. The upper limit against issued shares was 3.08%, with a cap of 900,000 shares and 2,000,000,000 yen; however, the cumulative total during the period is 522,600 shares and 1,629,768,479 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4526","jir_company_name":"\u7406\u7814\u30d3\u30bf\u30df\u30f3\u682a\u5f0f\u4f1a\u793e","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4526-20260901-01.pdf","jir_short_summary":"The target for acquisition is Riken Vitamin ordinary shares, totaling 164,300 shares and 536,497,492 yen, acquired through market purchases from August 1 to August 31, 2026. The upper limit against issued shares was 3.08%, with a cap of 900,000 shares and 2,000,000,000 yen; however, the cumulative total during the period is 522,600 shares and 1,629,768,479 yen.","jir_summary":"### News Overview\nRiken Vitamin has conducted treasury stock acquisition pursuant to Article 165, Paragraph 3 of the Companies Act. The target is ordinary shares, with the period from August 1, 2026 to August 31, 2026. Acquisition method is market purchases on the Tokyo Stock Exchange, and the initial upper limits were 900,000 shares and 2,000,000,000 yen. The total acquired shares were 164,300 with a total acquisition amount of 536,497,492 yen, while the cumulative total as of August 31, 2026 is 522,600 shares and 1,629,768,479 yen.\n\n### Impact on Shareholders and Outlook\nThe cumulative total to date has not reached the initial cap, and additional acquisitions may be anticipated depending on market conditions. Treasury stock acquisition is a common capital policy aimed at minimizing dilution and moderating the stock price, and investors should consider supply-demand balance and shareholder returns. Specific future acquisition policy or changes to the cap may be disclosed separately.","jir_financial_highlights":"Total number of shares acquired: 164,300 shares (Acquired during this period)\nTotal amount paid for acquisition: 536,497,492 yen (Total acquisition amount during this period)\nAcquisition period: 2026-08-01 to 2026-08-31 (Implemented within the period)","jir_category":"","jir_hashtags":"#\u7406\u7814\u30d3\u30bf\u30df\u30f3, #\u81ea\u793e\u682a\u8cb7\u3044","jir_key_figures":"Total number of shares acquired: 164,300 shares\nTotal amount paid for acquisition: 536,497,492 yen\nAcquisition period: 2026-08-01 to 2026-08-31","jir_meta_title":"\u3010\u7406\u7814\u30d3\u30bf\u30df\u30f3\u3011Treasury Stock Acquisition Status Disclosure\uff5cAugust 2026","jir_meta_description":"Status of treasury stock acquisition announced by Riken Vitamin. 164,300 shares totaling 536,497,492 yen acquired through market purchases in August. Cumulative total 522,600 shares and 1,629,768,479 yen. Further policy to be disclosed separately.","jir_og_title":"Riken Vitamin Treasury Stock Acquisition Status Disclosure\uff5cAugust 2026","jir_og_description":"Riken Vitamin discloses treasury stock acquisition. Displays the acquisition numbers within the period, cumulative totals, method, and caps. Watch for future developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16690,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-109850","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n